Logo image of SKIN

BEAUTY HEALTH CO/THE (SKIN) Stock Analyst Earnings Estimates

NASDAQ:SKIN - Nasdaq - US88331L1089 - Common Stock - Currency: USD

1.61  +0.01 (+0.63%)

After market: 1.66 +0.05 (+3.11%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
SKIN revenue by date.SKIN revenue by date.
260.1M
118.39%
365.9M
40.68%
397.991M
8.77%
334.78M
-15.88%
340.76M
1.79%
383.06M
12.41%
451.04M
17.75%
552.64M
22.53%
EBITDA
YoY % growth
SKIN ebitda by date.SKIN ebitda by date.
-15.46M
-452.14%
7.48M
148.38%
-60.778M
-912.54%
1.842M
103.03%
16.825M
813.41%
33.798M
100.88%
74.766M
121.21%
105.06M
40.52%
EBIT
YoY % growth
SKIN ebit by date.SKIN ebit by date.
-36.6M
-112.79%
-19.1M
47.81%
-93.017M
-387.00%
-81.559M
12.32%
-45.176M
44.61%
-32.749M
27.51%
-4.794M
85.36%
N/A
Operating Margin
SKIN operating margin by date.SKIN operating margin by date.
-14.07%-5.22%-23.37%-24.36%-13.26%-8.55%-1.06%N/A
EPS
YoY % growth
SKIN eps by date.SKIN eps by date.
-1.720.33
119.19%
0.16
-51.52%
-0.26
-259.38%
-0.27
-6.67%
-0.19
28.94%
N/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.11
-56.64%
-0.09
-832.59%
-0.05
-4,617.58%
-0.05
44.95%
-0.04
60.13%
-0.06
34.38%
-0.05
-12.89%
-0.04
17.64%
-0.03
30.00%
Revenue
Q2Q % growth
78.937M
-18.45%
78.506M
-3.56%
89.959M
-0.71%
83.664M
6.17%
87.251M
10.53%
92.514M
17.84%
100.16M
11.34%
98.328M
17.53%
103.63M
18.77%
EBITDA
Q2Q % growth
-2.043M
-103.95%
-85.343K
99.08%
6.247M
197.23%
5.381M
135.49%
5.863M
387.01%
4.692M
5,597.79%
6.732M
7.76%
8.568M
59.23%
9.282M
58.31%
EBIT
Q2Q % growth
-17.88M
-191.50%
-15.687M
7.68%
-7.937M
64.10%
-7.225M
66.42%
-9.366M
47.62%
-15.3M
2.46%
-13.26M
-67.07%
-11.424M
-58.12%
-10.71M
-14.35%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-0.09
-190.00%
-0.110.0220.82%
Q2 2024
Q2Q % growth
0.00
-99.41%
-0.050.05101.96%
Q1 2024
Q2Q % growth
-0.01
75.00%
-0.140.1392.83%
Q4 2023
Q2Q % growth
-0.07
-240.00%
-0.080.019.17%
Q3 2023
Q2Q % growth
0.10
100.00%
0.090.0115.34%
Q2 2023
Q2Q % growth
0.17
1,600.00%
0.060.11203.03%
Q1 2023
Q2Q % growth
-0.04
-118.18%
-0.02-0.02-76.49%
Q4 2022
Q2Q % growth
0.05
141.67%
0.040.0129.75%
Q3 2022
Q2Q % growth
0.05
103.07%
0.020.03159.50%
Q2 2022
Q2Q % growth
0.01
-88.89%
0.000.01983.24%
Q1 2022
Q2Q % growth
0.22
466.67%
0.000.225,492.16%
Q4 2021
Q2Q % growth
-0.12 -0.02-0.10-522.80%
Q3 2021
Q2Q % growth
-1.63 -0.01-1.62-11,522.10%
Q2 2021
Q2Q % growth
0.09 0.000.095,383.55%
Q1 2021
Q2Q % growth
-0.06 -0.03-0.03-135.29%
SKIN Yearly EPS VS EstimatesSKIN Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 -0.5 -1 -1.5 -2
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
78.8M
-19.10%
75.407M3.393M4.50%
Q2 2024
Q2Q % growth
90.6M
-22.89%
100.48M-9.88M-9.83%
Q1 2024
Q2Q % growth
81.403M
-5.67%
82.144M-741K-0.90%
Q4 2023
Q2Q % growth
96.8M
-1.33%
89.378M7.422M8.30%
Q3 2023
Q2Q % growth
97.4M
9.68%
118.52M-21.12M-17.82%
Q2 2023
Q2Q % growth
117.5M
13.53%
118.41M-910K-0.77%
Q1 2023
Q2Q % growth
86.3M
14.46%
92.176M-5.876M-6.37%
Q4 2022
Q2Q % growth
98.1M
25.93%
96.499M1.601M1.66%
Q3 2022
Q2Q % growth
88.8M
30.40%
82.162M6.638M8.08%
Q2 2022
Q2Q % growth
103.5M
55.64%
84.922M18.578M21.88%
Q1 2022
Q2Q % growth
75.4M
58.74%
69.186M6.214M8.98%
Q4 2021
Q2Q % growth
77.9M
-34.59%
72.522M5.378M7.42%
Q3 2021
Q2Q % growth
68.1M 58.152M9.948M17.11%
Q2 2021
Q2Q % growth
66.5M
371.63%
50.195M16.305M32.48%
Q1 2021
Q2Q % growth
47.5M 44.982M2.518M5.60%
SKIN Yearly Revenue VS EstimatesSKIN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M 500M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS1.15% 1.15% 0% -27.12%
Revenue0% 0% 0% -1.01%